| Hematologic, biochemical, and protein electrophoretic values in captive tawny owls (Strix aluco) V Spagnolo, V Crippa, A Marzia, I Alberti, P Sartorelli Veterinary clinical pathology 37 (2), 225-228, 2008 | 43 | 2008 |
| Reference intervals for hematologic and biochemical constituents and protein electrophoretic fractions in captive common buzzards (Buteo buteo) V Spagnolo, V Crippa, A Marzia, P Sartorelli Veterinary Clinical Pathology 35 (1), 82-87, 2006 | 38 | 2006 |
| Effects of blocking CD24 and CD47 ‘don't eat me’signals in combination with rituximab in mantle‐cell lymphoma and chronic lymphocytic leukaemia A Aroldi, M Mauri, D Ramazzotti, M Villa, F Malighetti, V Crippa, F Cocito, ... Journal of Cellular and Molecular Medicine 27 (20), 3053-3064, 2023 | 5 | 2023 |
| Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients D Fontana, I Crespiatico, V Crippa, F Malighetti, M Villa, F Angaroni, ... Nature Communications 14 (1), 5982, 2023 | 4 | 2023 |
| Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering V Crippa, F Malighetti, M Villa, A Graudenzi, R Piazza, L Mologni, ... Computers in Biology and Medicine 162, 107064, 2023 | 4 | 2023 |
| Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR F Foschi, A Tinivella, V Crippa, L Pinzi, L Mologni, D Passarella, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 239-245, 2023 | 4 | 2023 |
| Intra‐abdominal fluid aspirate from a dog V Crippa, G Ghisleni, G Avallone, M Caniatti Diagnostic Cytopathology 44 (2), 119-120, 2016 | 3 | 2016 |
| Characterization of SARS-CoV-2 mutational signatures from 1.5+ million raw sequencing samples A Aroldi, F Angaroni, D D’Aliberti, S Spinelli, I Crespiatico, V Crippa, ... Viruses 15 (1), 7, 2022 | 2 | 2022 |
| First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis I Crespiatico, M Zaghi, C Mastini, D D’Aliberti, M Mauri, CM Mercado, ... Blood 143 (14), 1399-1413, 2024 | 1 | 2024 |
| Characterization of molecular evolution in myelodysplastic neoplasms I Civettini, V Crippa, F Malighetti, M Villa, A Aroldi, F Cavalca, A Graudenzi, ... Cancer Research 84 (6_Supplement), 6208-6208, 2024 | | 2024 |
| Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers M Villa, G Cazzaniga, M Bolognesi, V Crippa, F Malighetti, A Aroldi, ... Cancer Research 84 (6_Supplement), 861-861, 2024 | | 2024 |
| Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer V Crippa, D Fontana, I Civettini, L Mologni, R Piazza, ... Cancer Research 84 (6_Supplement), 4885-4885, 2024 | | 2024 |
| Control-FREEC viewer: a tool for the visualization and exploration of copy number variation data V Crippa, E Fina, D Ramazzotti, R Piazza BMC bioinformatics 25 (1), 72, 2024 | | 2024 |
| Characterizing Molecular Pathways and Therapeutic Prospects in MDS/MPN Neoplasms: A Focus on SETBP1 Mutations V Crippa Università degli Studi di Milano-Bicocca, 2024 | | 2024 |
| First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis I Crespiatico, M Zaghi, C Mastini, D D'Aliberti, M Mauri, CM Mercado, ... Blood 142, 4135, 2023 | | 2023 |
| Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution D Fontana, V Crippa, G Bassi, D D'Aliberti, M Mauri, S Spinelli, C Mastini, ... | | 2022 |
| CELL BLOCKS OF CANINE AND FELINE EFFUSION V Crippa Università degli Studi di Milano, 2016 | | 2016 |
| F08–PROBING THE CHEMICAL SPACE OF DUAL KINASE INHIBITORS: OPTIMIZATION OF SYNTHETIC LINES AND IDENTIFICATION OF NOVEL SCAFFOLDS L Destro, ML Introvigne, V Crippa, L Mologni, F Prati, E Caselli, A Zambon Book of abstract, 23, 0 | | |
